Navegar por autor "Miranda Filloy, José Alberto"

Mostrando ítems 1-20 de 95

A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis

2013- Sopeña Perez-Argüelles, Bernardo; Miranda Filloy, José Alberto
A nonsynonymous functional variant of the ITGAM gene is not involved in biopsy-proven giant cell arteritis.

2011- Sopeña Perez-Argüelles, Bernardo; Miranda Filloy, José Alberto
A Single Amino Acid In The beta 1 Chain Of HLA-DR Explains The Majority Of The HLA Association With Giant Cell Arteriti

2013- Sopeña Perez-Argüelles, Bernardo; Miranda Filloy, José Alberto
Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis

2014- González Juanatey, Carlos; Miranda Filloy, José Alberto
Adiponectin and resistin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-alpha antagonist therapy

2013- González Juanatey, Carlos; Miranda Filloy, José Alberto
Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis

2011- González Juanatey, Carlos; Vázquez Rodríguez, Tomás Ramón; Miranda Filloy, José Alberto
Analysis of the Interferon Gamma (rs2430561,+874T/A) Functional Gene Variant in Relation to the Presence of Cardiovascular Events in Rheumatoid Arthritis

2012- González Juanatey, Carlos; Miranda Filloy, José Alberto
Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy

2012- González Juanatey, Carlos; Vázquez Rodríguez, Tomás Ramón; Miranda Filloy, José Alberto; Testa Fernández, Ana; García Porrúa, Carlos; [et al.]
Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients

2015- González Juanatey, Carlos; Miranda Filloy, José Alberto
Antitumour necrosis factor alpha treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients

2014- González Juanatey, Carlos; Miranda Filloy, José Alberto
Antitumour necrosis factor-alpha therapy modulates angiopoietin-2 serum levels in non-diabetic ankylosing spondylitis patients

2013- González Juanatey, Carlos; Miranda Filloy, José Alberto
Apelin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-alpha antagonist therapy.

2013- González Juanatey, Carlos; Miranda Filloy, José Alberto
Association of acid phosphatase locus 1

2013- González Juanatey, Carlos; Miranda Filloy, José Alberto
Association of acid phosphatase locus 1

2011- González Juanatey, Carlos; Miranda Filloy, José Alberto
Association of HLA-B

2014- Miranda Filloy, José Alberto
Association of HLA-b

2015- Miranda Filloy, José Alberto
Association of HLA-B

2015- Miranda Filloy, José Alberto
Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis.

2012- González Juanatey, Carlos; Miranda Filloy, José Alberto
Association study of MIA3 rs17465637 polymorphism with cardiovascular disease in rheumatoid arthritis patients

2012- González Juanatey, Carlos; Miranda Filloy, José Alberto
Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-alpha antagonist therapy

2013- González Juanatey, Carlos; Miranda Filloy, José Alberto